Cyclacel Pharmaceuticals (CYCC) Receives Non-Compliance Notification From NASDAQ
Tweet Send to a Friend
Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) received a Nasdaq Staff Deficiency Letter on October 27, 2009 indicating that the Company fails ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
